$REAL
TheRealReal, Inc.

2023 Q4 Form 10-Q Financial Statement

#000157322123000086 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $143.4M $133.2M
YoY Change -10.2% -6.68%
Cost Of Revenue $37.32M $39.10M
YoY Change -40.8% -31.31%
Gross Profit $106.0M $94.07M
YoY Change 9.77% 9.67%
Gross Profit Margin 73.97% 70.64%
Selling, General & Admin $119.7M $44.79M
YoY Change -11.04% -4.42%
% of Gross Profit 112.88% 47.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.165M $7.740M
YoY Change 10.13% 7.57%
% of Gross Profit 7.7% 8.23%
Operating Expenses $119.7M $116.6M
YoY Change -11.04% -11.23%
Operating Profit -$13.66M -$22.49M
YoY Change -64.01% -50.6%
Interest Expense -$595.0K $2.673M
YoY Change -5.1% -0.07%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income -$21.66M -$22.90M
YoY Change -43.8% -51.47%
Income Tax $36.00K $47.00K
% Of Pretax Income
Net Earnings -$21.69M -$22.95M
YoY Change -43.82% -51.44%
Net Earnings / Revenue -15.13% -17.23%
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share -$0.21 -$0.22
COMMON SHARES
Basic Shares Outstanding 103.4M shares 102.1M shares
Diluted Shares Outstanding 102.6M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $175.7M $170.8M
YoY Change -40.19% -43.15%
Cash & Equivalents $175.7M $170.8M
Short-Term Investments
Other Short-Term Assets $20.77M $20.90M
YoY Change -10.84% -22.86%
Inventory $22.25M $24.66M
Prepaid Expenses
Receivables $17.23M $13.56M
Other Receivables $0.00 $0.00
Total Short-Term Assets $235.9M $230.0M
YoY Change -36.62% -42.4%
LONG-TERM ASSETS
Property, Plant & Equipment $104.1M $106.8M
YoY Change -7.63% 7.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.627M $5.473M
YoY Change 104.69% 96.87%
Total Long-Term Assets $211.0M $222.7M
YoY Change -13.32% -5.29%
TOTAL ASSETS
Total Short-Term Assets $235.9M $230.0M
Total Long-Term Assets $211.0M $222.7M
Total Assets $446.9M $452.7M
YoY Change -27.41% -28.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.961M $8.088M
YoY Change -24.71% -18.3%
Accrued Expenses $77.12M $66.53M
YoY Change -5.42% -7.31%
Deferred Revenue $2.214M $1.646M
YoY Change -37.62% -55.49%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $188.9M $176.9M
YoY Change -8.99% -8.84%
LONG-TERM LIABILITIES
Long-Term Debt $452.4M $451.8M
YoY Change 0.57% 0.63%
Other Long-Term Liabilities $4.083M $4.097M
YoY Change 25.48% 58.92%
Total Long-Term Liabilities $4.083M $4.097M
YoY Change 25.48% 58.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $188.9M $176.9M
Total Long-Term Liabilities $4.083M $4.097M
Total Liabilities $750.2M $742.7M
YoY Change -4.52% -4.25%
SHAREHOLDERS EQUITY
Retained Earnings -$1.120B -$1.098B
YoY Change 17.71% 20.32%
Common Stock $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$303.3M -$290.0M
YoY Change
Total Liabilities & Shareholders Equity $446.9M $452.7M
YoY Change -27.41% -28.65%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$21.69M -$22.95M
YoY Change -43.82% -51.44%
Depreciation, Depletion And Amortization $8.165M $7.740M
YoY Change 10.13% 7.57%
Cash From Operating Activities $10.52M -$10.93M
YoY Change 184.56% 48.69%
INVESTING ACTIVITIES
Capital Expenditures $6.730M $8.120M
YoY Change -36.91% -180.91%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$6.730M -$8.120M
YoY Change -36.91% -19.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 262.0K -80.00K
YoY Change -18.89% -104.13%
NET CHANGE
Cash From Operating Activities 10.52M -10.93M
Cash From Investing Activities -6.730M -8.120M
Cash From Financing Activities 262.0K -80.00K
Net Change In Cash 4.055M -19.13M
YoY Change -161.01% 23.81%
FREE CASH FLOW
Cash From Operating Activities $10.52M -$10.93M
Capital Expenditures $6.730M $8.120M
Free Cash Flow $3.793M -$19.05M
YoY Change -154.43% -809.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
15757000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4097000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3254000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
742700000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
785733000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
807912000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
781060000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1097932000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-290019000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-170092000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
452681000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
615641000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133172000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142703000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
405931000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
443838000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
39100000 usd
us-gaap Gross Profit
GrossProfit
270229000 usd
us-gaap Gross Profit
GrossProfit
252081000 usd
CY2023Q3 us-gaap Marketing Expense
MarketingExpense
11591000 usd
CY2022Q3 us-gaap Marketing Expense
MarketingExpense
13511000 usd
us-gaap Marketing Expense
MarketingExpense
44460000 usd
us-gaap Marketing Expense
MarketingExpense
48455000 usd
CY2023Q3 real Operations And Technology Expense
OperationsAndTechnologyExpense
61038000 usd
CY2022Q3 real Operations And Technology Expense
OperationsAndTechnologyExpense
70782000 usd
real Operations And Technology Expense
OperationsAndTechnologyExpense
194645000 usd
real Operations And Technology Expense
OperationsAndTechnologyExpense
207159000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44788000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1002000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6717000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1360000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
2673000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
2675000 usd
us-gaap Interest Expense
InterestExpense
8018000 usd
us-gaap Interest Expense
InterestExpense
8014000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
247000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22949000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47258000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.45
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102648790 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101087793 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101087793 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95036618 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95036618 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-170092000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-208000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9280000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-82500000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
147410000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-856000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103310783 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103310783 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99088172 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99088172 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-951153000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
56926000 usd
us-gaap Cost Of Revenue
CostOfRevenue
135702000 usd
us-gaap Cost Of Revenue
CostOfRevenue
191757000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
94072000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
85777000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47012000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
138959000 usd
us-gaap Restructuring Charges
RestructuringCharges
37396000 usd
us-gaap Restructuring Charges
RestructuringCharges
275000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
116561000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
131305000 usd
us-gaap Operating Expenses
OperatingExpenses
415460000 usd
us-gaap Operating Expenses
OperatingExpenses
403299000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22489000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-45528000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-145231000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-151218000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2260000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
133000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22902000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47195000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-146532000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-157739000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96696417 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96696417 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-243520000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-41330000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-275584000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-203000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
637000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12964000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-57412000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-69317000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
328000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-23000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
900000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14164000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-107113000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1941000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11181000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-47258000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-141255000 usd
us-gaap Net Income Loss
NetIncomeLoss
-146779000 usd
us-gaap Net Income Loss
NetIncomeLoss
-157835000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23530000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20255000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26293000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
37020000 usd
real Reduction Of Operating Lease Right Of Use Assets
ReductionOfOperatingLeaseRightOfUseAssets
12999000 usd
real Reduction Of Operating Lease Right Of Use Assets
ReductionOfOperatingLeaseRightOfUseAssets
14598000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1565000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1133000 usd
real Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
575000 usd
real Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
575000 usd
real Accretion Of Debt Discounts And Issuance Costs
AccretionOfDebtDiscountsAndIssuanceCosts
1920000 usd
real Accretion Of Debt Discounts And Issuance Costs
AccretionOfDebtDiscountsAndIssuanceCosts
1942000 usd
real Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software
GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware
-182000 usd
real Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software
GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware
-432000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
33817000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
8836000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1798000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
738000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2922000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2119000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9474000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6243000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1897000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6543000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2856000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
391000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21399000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-13074000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1550000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4067000 usd
real Increase Decrease In Accrued Consignor Payable
IncreaseDecreaseInAccruedConsignorPayable
-15018000 usd
real Increase Decrease In Accrued Consignor Payable
IncreaseDecreaseInAccruedConsignorPayable
729000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1499000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-4494000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-118000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
409000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-71791000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95255000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25528000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35398000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26255000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2906000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
446000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
900000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
501000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
28000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300439000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3778000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-107225000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-117732000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
293793000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
418171000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186568000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300439000 usd
us-gaap Interest Paid Net
InterestPaidNet
5522000 usd
us-gaap Interest Paid Net
InterestPaidNet
5496000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
227000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
256000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2293000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4487000 usd
real Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash
CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash
1070000 usd
real Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash
CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash
2159000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
608000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1289000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve, standalone selling price related to revenue transactions, valuation of inventory, software development costs, stock-based compensation, incremental borrowing rates related to lease liability, valuation of deferred taxes, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our 2022 Form 10-K. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2022 Form 10-K for a complete summary of our significant accounting policies.</span></div>
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
170811000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
293793000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
15800000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170811000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
293793000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300439000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
15757000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186568000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
293793000 usd
us-gaap Inventory Write Down
InventoryWriteDown
8800000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1800000 usd
CY2023Q3 real Rights To Recover Products From Customers
RightsToRecoverProductsFromCustomers
7200000 usd
CY2022Q4 real Rights To Recover Products From Customers
RightsToRecoverProductsFromCustomers
6100000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, restricted cash and accounts receivable. At times, such amount may exceed federally-insured limits. The Company is closely monitoring ongoing events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally. The Company reduces credit risk by placing its cash, cash equivalents, restricted cash and investments with major financial institutions with high credit ratings within the United States. The Company has not experienced any realized losses on cash, cash equivalents and restricted cash to date; however, no assurances can be provided.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023 and December 31, 2022, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the nine months ended September 30, 2023 and 2022.</span></div>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170811000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
175427000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
175814000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
68621000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
63135000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
106806000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112679000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7600000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6600000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
22900000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19700000 usd
CY2023Q3 us-gaap Impairment Of Leasehold
ImpairmentOfLeasehold
300000 usd
us-gaap Impairment Of Leasehold
ImpairmentOfLeasehold
7500000 usd
CY2023Q3 real Accrued Returns Reserve Current
AccruedReturnsReserveCurrent
23205000 usd
CY2022Q4 real Accrued Returns Reserve Current
AccruedReturnsReserveCurrent
22233000 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
20267000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
15111000 usd
CY2023Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
473000 usd
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
484000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
7094000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8531000 usd
CY2023Q3 real Site Credit Liability
SiteCreditLiability
15491000 usd
CY2022Q4 real Site Credit Liability
SiteCreditLiability
11813000 usd
CY2023Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5195000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
8729000 usd
CY2023Q3 real Accrued Property And Equipment
AccruedPropertyAndEquipment
1242000 usd
CY2022Q4 real Accrued Property And Equipment
AccruedPropertyAndEquipment
11417000 usd
CY2023Q3 real Accrued Shipping
AccruedShipping
2268000 usd
CY2022Q4 real Accrued Shipping
AccruedShipping
5715000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1646000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3549000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1741000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1166000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3837000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
4544000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
82459000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
93292000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8536000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10841000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26293000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37020000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
200000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
400000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
600000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1300000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5100000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
7200000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
17900000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
21700000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1200000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1500000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
3800000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
4300000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
26300000 usd
CY2023Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q3 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
1200000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
700000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7084000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
26794000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
27706000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
27534000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
23528000 usd
CY2023Q3 real Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
40666000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
153312000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23549000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
129763000 usd
real Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
27028000 usd
real Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
20138000 usd
real Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurement Of Right Of Use Asset And Lease Liabilities
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementOfRightOfUseAssetAndLeaseLiabilities
6006000 usd
real Right Of Use Asset Obtained In Exchange For Operating Lease Liability Including Re Measurement Of Right Of Use Asset And Lease Liabilities
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingReMeasurementOfRightOfUseAssetAndLeaseLiabilities
2156000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
2 flagship_store
us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
2 neighborhood_store
us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
2 consignment_office
us-gaap Restructuring Charges
RestructuringCharges
37400000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
26300000 usd
us-gaap Impairment Of Leasehold
ImpairmentOfLeasehold
7500000 usd
us-gaap Severance Costs1
SeveranceCosts1
3000000 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
1300000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
700000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
255200000 usd
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
291800000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3000000.0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-22949000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22949000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-47258000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47258000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-146779000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-146779000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-157835000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-157835000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102648790 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102648790 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96696417 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96696417 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101087793 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101087793 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95036618 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95036618 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34449477 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33516697 shares

Files In Submission

Name View Source Status
0001573221-23-000086-index-headers.html Edgar Link pending
0001573221-23-000086-index.html Edgar Link pending
0001573221-23-000086.txt Edgar Link pending
0001573221-23-000086-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
real-20230930.htm Edgar Link pending
real-20230930.xsd Edgar Link pending
real-2023930xex311.htm Edgar Link pending
real-2023930xex312.htm Edgar Link pending
real-2023930xex321.htm Edgar Link pending
real-2023930xex322.htm Edgar Link pending
real2023930-ex101.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
real-20230930_lab.xml Edgar Link unprocessable
real-20230930_pre.xml Edgar Link unprocessable
real-20230930_htm.xml Edgar Link completed
real-20230930_cal.xml Edgar Link unprocessable
real-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable